4Filing Date: Aug 20, 2026
Hims & Hers Health
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001837817-26-000011
Total Value$691.8K
Trades1
Insiders1
Transaction Details
Boughton Soleil
Chief Legal Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-25.11K
Price$27.55
Total Value$691.8K
Shares Owned After313.96K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
Post-Transaction Holdings
Boughton Soleil · Chief Legal Officer
| Security | Shares | Change |
|---|---|---|
| Class A Common Stock | 313.96K | -25.11K (-7.41%) |
auto_awesomeDeep Analysis
Deep Analysis
Hims & Hers Chief Legal Officer Soleil Boughton sold 25,111 shares in a pre-arranged Rule 10b5-1 open-market sale, a passive transaction.
lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-19
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Hims & Hers Health, Inc. (HIMS)
CIK: 0001773751
--- Reporting Owner ---
Name: Boughton Soleil
CIK: 0001837817
Role: Officer (Chief Legal Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Class A Common Stock
Date: 2026-08-19 | Code: S (Open market sale)
Shares: -25,111 | Price: $27.55
Total Value: $691,808.05
Shares Owned After: 313,964 | Ownership: D (Direct)
Footnotes:
[F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Footnotes (Complete Index) ---
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Signature ---
/s/ /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton (2026-08-20)